Clinic Trial on Establishing a Prevention System for Acute Mountain Sickness Based on Beet Root Extract.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400081483

Enrollment

Unknown

Registered

2024-03-01

Start date

2024-03-01

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

intervention group:Beet Root Extract

control group:Comfort

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: (1) Age 18-55 years old; (2) Those who voluntarily sign informed consent, agree to participate in the experiment and comply with the program.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) Long-term experience in plateau (more than 3 months); (2) The presence of symptoms or related history of any major disease, including but not limited to heart, liver, kidney disease or other acute or chronic digestive tract disease, respiratory disease, bone and joint disease, as well as diseases of the blood, endocrine, neurological, psychiatric and other systems, or any other disease or physiological condition that may interfere with the test results; (3) Have a history of malignant tumors or malignant tumors, and have received radiotherapy or chemotherapy; (4) in the state of acute disease, such as acute respiratory infection, acute gastroenteritis, etc.; (5) Patients with acute and chronic oral and maxillofacial diseases, such as pericoronitis, pulpitis, mumps, etc.; (6) Pregnant or lactating women, or pregnancy test positive during the screening period; Or do not agree to effective contraception within 3 months after the end of the trial; (7) a known severe allergy, non-allergic drug reaction or multiple drug allergy, or a known hypersensitivity reaction to an investigational drug (active API or formulation excipient); (8) The investigator believes that the screening period examination has clinical significance and is not suitable for participation in the investigator; (9) For scientific reasons, compliance reasons, or subject safety reasons, the investigator does not consider it appropriate to participate in this study.

Design outcomes

Primary

Measure	Time frame
Incidence of acute mountain sickness;	—

Secondary

Measure	Time frame
Vivo measurement;Nitrate ion content in body fluids;	—

Countries

China

Contacts

Public ContactLei Chen

West China Hospital of Sichuan University

leilei_25@126.com+86 189 8060 5819

Outcome results